These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4517136)

  • 21. Male rat sexual behavior compared after 6-OHDA and electrolytic lesions in the dorsal NA bundle region of the midbrain.
    Clark TK
    Brain Res; 1980 Dec; 202(2):429-43. PubMed ID: 7437909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.
    Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects on body weight of central 6-hydroxydopamine lesions in obese (ob/ob) and diabetes (db/db) mice.
    Lorden JF
    J Comp Physiol Psychol; 1979 Dec; 93(6):1085-96. PubMed ID: 521520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventral noradrenergic bundle "area" lesions producing reduced body weight and activity.
    Bellinger LL; Bernardis LL; Dill RE
    Physiol Behav; 1980 Nov; 25(5):783-9. PubMed ID: 7003618
    [No Abstract]   [Full Text] [Related]  

  • 25. Food intake and body weight: effects of specific and non-specific lesions in the midbrain path of the ascending noradrenergic neurons of the rat.
    Oltmans GA; Lorden JF; Margules DL
    Brain Res; 1977 Jun; 128(2):293-308. PubMed ID: 871916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome.
    Fibiger HC; Zis AP; McGeer EG
    Brain Res; 1973 May; 55(1):135-48. PubMed ID: 4145913
    [No Abstract]   [Full Text] [Related]  

  • 27. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-Hydroxydopamine lesion of the ventral noradrenergic bundle blocks the effect of amphetamine on hippocampal acetylcholine.
    Robinson SE
    Brain Res; 1986 Nov; 397(1):181-4. PubMed ID: 3099971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight.
    King BM
    Physiol Behav; 2006 Feb; 87(2):221-44. PubMed ID: 16412483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epinephrine in rat hypothalamus: antagonism by desipramine of 6-hydroxydopamine-induced depletion.
    Tessel RE; Kennedy LE; Burgess SK; Borchardt RT
    Brain Res; 1978 Sep; 153(3):615-7. PubMed ID: 698800
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of intraventricular 6-hydroxydopamine and replacement therapy with norepinephrine, dopamine, and serotonin on self-stimulation in diencephalic and mesencephalic regions in the rat.
    Olds ME
    Brain Res; 1975 Nov; 98(2):327-42. PubMed ID: 1182523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of chronic intracranial injection of low and high concentrations of guanethidine in the rat.
    Evans BK; Singer G; Armstrong S; Saunders PE; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(2):219-28. PubMed ID: 1096174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanisms.
    Ruiz M; Monti JM
    Pharmacology; 1975; 13(4):281-6. PubMed ID: 1187753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontogeny of amphetamine anorexia and insulin hyperphagia in the rat.
    Lytle LD; Moorcroft WH; Campbell BA
    J Comp Physiol Psychol; 1971 Dec; 77(3):388-93. PubMed ID: 5286908
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothalamic knife-cut hyperphagia and obesity in weanling rats.
    Simson EL; Gold RM
    Physiol Behav; 1981 Sep; 27(3):533-8. PubMed ID: 6950438
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of lesions in the ventral noradrenergic tract produced by microinjection of 6-hydroxydopamine on gonadotropin release in the rat.
    Martinovic JV; McCann SM
    Endocrinology; 1977 Apr; 100(4):1206-13. PubMed ID: 837882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic obesity and noradrenergic neural pathways.
    Nutr Rev; 1974 Mar; 32(3):83-4. PubMed ID: 4816354
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurochemical basis of the dorsal bundle extinction effect.
    Mason ST; Fibiger HC
    Pharmacol Biochem Behav; 1979 Mar; 10(3):373-80. PubMed ID: 450950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.